Segunda línea en cáncer de pulmón de células no - page 8

Median os

8,2 m,

1-y

40,8%

Median PFS

1,9 m,

1-y

20%

CHECKMATE 063: previously treated SCC

Rizvi N, et al. Lancet Oncol 2015

•

N: 117 SCC

•

65% >3-4 previous systemic

treatments

•

RR 14.5%

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3,4,5,6,7 9,10,11,12,13,14,15,16,17,18,...41